SABS 424B3: Secondary offering

SAB Biotherapeutics

Filed with the SEC on · accession 0001193125-26-361180

SABS filed a 424B3 (prospectus (offering)) with the SEC on Aug 21, 2026. The final terms of an offering of shares or bonds. The stock moved +2.2% by the first close after the filing.

Summary of the filing

SAB Biotherapeutics filed a prospectus supplement registering up to 250,000,000 shares of common stock for resale by selling stockholders, consisting of shares issuable upon conversion of Series B Convertible Preferred Stock and related warrants.

Key details

Maximum shares of common stock offered for resale$250.0M
Closing price per share on August 18, 2026$4
IssuerSAB Biotherapeutics, Inc.
Selling stockholderSESSA CAPITAL (MASTER) L.P.
Selling stockholderRA Capital Healthcare Fund, L.P.
Selling stockholderAventis Inc
Selling stockholderEntities Affiliated with Vivo Capital, LLC
Selling stockholderCommodore Capital Master LP
Selling stockholderCDK ASSOCIATES, LLC

How SABS stock reacted

Close before

$3.70

Aug 20, 2026

First close after

+2.16%

$3.78

5 trading days

+6.22%

$3.93

Since filing

-20.54%

$2.94

✦ Ask GOAX AI about this filing — what it means for SABS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SABS?

Click here

Frequently asked questions

What did SABS file with the SEC on Aug 21, 2026?

SABS filed a 424B3 (Secondary offering). SAB Biotherapeutics filed a prospectus supplement registering up to 250,000,000 shares of common stock for resale by selling stockholders, consisting of shares issuable upon conversion of Series B Convertible Preferred Stock and related warrants.

What does a secondary offering mean for SABS stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did SABS stock react to this filing?

SABS closed at $3.70 before the filing and $3.78 on Aug 21, 2026 (+2.16%). Five trading days later: $3.93 (+6.22%).

Other SABS SEC filings

Get alerts when SABS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days